Silexion Therapeutics SLXN
NASDAQ SLXN
$0.26 -0.02 (-7.14%)
At close: Oct 2, 2026 · 4:00 PM EDT

Silexion Therapeutics (SLXN) Income from Non-Controlling Interests (2023 - 2024)

Updated

Silexion Therapeutics (SLXN) reported Income from Non-Controlling Interests of $76,000 for FY2024, down 54.2% from $166,000 in FY2023.

Analysis

Silexion Therapeutics (SLXN) Income from Non-Controlling Interests (2023 - 2024) Analysis & Trends

  • According to Business Quant data, Income from Non-Controlling Interests came in at $166,000 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.00 Mn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -2.00 Mn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -7.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 1.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 10.00 Mn
10 Silexion Therapeutics 178,711.77 -19.70 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 9,000.00
Jun 30, 2024 17,000.00
Mar 31, 2024 50,000.00
Dec 31, 2023 -48,000.00
Sep 30, 2023 22,000.00
Jun 30, 2023 223,000.00
API Access

Silexion Therapeutics Income from Non-Controlling Interests API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=SLXN&period=max&api_key=YOUR_API_KEY